Nd Substantially Enhances Their Safety The Project Is Now Entering Final Process Validation Phase Of Medium Fill Procedures New Offering Reinforces Amaran Biotech 39s Recognition Asa Leading Cdmo Contract Development Amp Manufacturing Organization With Many Years Extensive Experience In Processes High Value Biopharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HSINCHU, July 13, 2022 /PRNewswire/ Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes the risks of human factors affecting the quality of the pharmaceutical products, and substantially enhances their safety. The project is now entering the final process validation phase of the medium fill procedures. The new offering reinforces Amaran Biotech's recognition as a leading CDMO (contract development & manufacturing organization) with many years of extensive experience in the development of manufacturing processes of high-value biopharmaceuticals, analysis services, and premium solutions for cGMP production. It also strengthens its position as the OEM of active pharmaceutical ingredients (APIs) of OBI Pharma's active immune-oncologic therapeutic products. Amaran Biotech's Quality Managemen ....

United States , United Kingdom , Northern Samar , City Of , Tessie Che , Quillaja Saponaria , Bio Asia , Optimer Pharmaceuticals Inc , London Stock Exchange , Amaran Biotechnology Inc , Prnewswire Amaran Biotechnology Inc , Pharma Inc , Biotechnology Inc , Amaran Biotech , Quality Management Vice President Jamie Hung , Herpes Zoster , Fully Automated Aseptic Filling Line , Hsinchu Biomedical Science Park , General Manager , Optimer Pharmaceuticals , July 13 , 022 Prnewswire Amaran Biotechnology Inc , A Subsidiary Of Taiwan 39s Obi Pharma Inc , Oday Announced That The Construction Of Its Fully Automated Aseptic Filling Line And Facilities , A First In Taiwan , As Been Completed The New Facility Minimizes Risks Of Human Factors Affecting Quality Pharmaceutical Products ,